A plan for the US Food and Drug Administration to propose banning formaldehyde and certain formaldehyde-releasing chemicals ...
5h
Hosted on MSNHims & Hers Super Bowl controversy: What the ad left out about its 'alternative' weight-loss drugsThe telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide ...
Telehealth company Hims & Hers is pushing the boundaries of drug compounding and testing the limits of regulators.
Grants from the National Institutes of Health come with additional money for overhead. A planned $4 billion cut would leave ...
The Trump administration recently removed heath data from government websites, which spurred a federal lawsuit filed Tuesday ...
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...
A variety of pastries have been recalled due to listeria and salmonella concerns, according to the Food and Drug ...
A clinical trial comparing a one-page medication handout proposed by the U.S. Food and Drug Administration (FDA) with an ...
Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...
The FDA has set the second highest risk level for a nationwide baked goods recall—which includes some pastries sold at Dunkin ...
Now that the U.S. Food and Drug Administration has banned Red Dye No. 3, artificial food dyes are under increasing scrutiny.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results